The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma

被引：0
|
作者：
Sundeep Singh
Shou-jiang Tang
Jayaprakash Sreenarasimhaiah
Luis F. Lara
Ali Siddiqui
机构：
[1] Stanford University,Division of Gastroenterology and Hepatology
[2] University of Mississippi,Division of Digestive Diseases
[3] University of Texas-Southwestern Medical Center,Division of Digestive and Liver Diseases
[4] Baylor University Medical Center,Division of Gastroenterology and Hepatology, Jefferson Digestive Disease Institute
[5] Thomas Jefferson University,undefined
来源：
Digestive Diseases and Sciences | 2011年 / 56卷
关键词：
Serum carbohydrate antigen; CA19-9; Pancreatic cancer; Cholangiocarcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2491 / 2496
页数：5
相关论文
共 50 条
  • [1] The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma
    Singh, Sundeep
    Tang, Shou-jiang
    Sreenarasimhaiah, Jayaprakash
    Lara, Luis F.
    Siddiqui, Ali
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2491 - 2496
  • [2] Serum CA19-9 determination in the management of pancreatic cancer
    vandenBosch, RP
    vanEijck, CHJ
    Mulder, PGH
    Jeekel, J
    HEPATO-GASTROENTEROLOGY, 1996, 43 (09) : 710 - 713
  • [3] The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer
    Ni, XG
    Bai, XF
    Mao, YL
    Shao, YF
    Wu, JX
    Shan, Y
    Wang, CF
    Wang, J
    Tian, YT
    Liu, Q
    Xu, DK
    Zhao, P
    EJSO, 2005, 31 (02): : 164 - 169
  • [4] Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis
    Huang, Zhe
    Liu, Fang
    TUMOR BIOLOGY, 2014, 35 (08) : 7459 - 7465
  • [5] CA19-9 in intrahepatic cholangiocarcinoma. A diagnostic and prognostic armamentarium?
    Juntermanns, B.
    Kaiser, G. M.
    Gutierrez, S. Itani
    Heuer, M.
    Buechter, M.
    Kahraman, A.
    Reis, H.
    Kasper, S.
    Paul, A.
    Fingas, C. D.
    CHIRURG, 2018, 89 (06): : 466 - 471
  • [6] SERUM CONCENTRATION AND IMMUNOHISTOCHEMICAL LOCALIZATION OF SPAN-1 ANTIGEN IN PANCREATIC-CANCER - A COMPARISON WITH CA19-9 ANTIGEN
    TAKEDA, S
    NAKAO, A
    ICHIHARA, T
    SUZUKI, Y
    NONAMI, T
    HARADA, A
    KOSHIKAWA, T
    TAKAGI, H
    HEPATO-GASTROENTEROLOGY, 1991, 38 (02) : 143 - 148
  • [7] Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis
    Liang, Bin
    Zhong, Liansheng
    He, Qun
    Wang, Shaocheng
    Pan, Zhongcheng
    Wang, Tianjiao
    Zhao, Yujie
    MEDICAL SCIENCE MONITOR, 2015, 21 : 3555 - 3563
  • [8] The usefulness of serial changes in serum CA19-9 levels in the diagnosis of pancreatic cancer
    Tanaka, N
    Okada, S
    Ueno, H
    Okusaka, T
    Ikeda, M
    PANCREAS, 2000, 20 (04) : 378 - 381
  • [9] Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9
    Ritchie, Shawn A.
    Chitou, Bassirou
    Zheng, Qingan
    Jayasinghe, Dushmanthi
    Jin, Wei
    Mochizuki, Asuka
    Goodenowe, Dayan B.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (21) : 6604 - 6612
  • [10] Pancreatic cancer serum biomarker PC-594:Diagnostic performance and comparison to CA19-9
    Shawn A Ritchie
    Bassirou Chitou
    Qingan Zheng
    Dushmanthi Jayasinghe
    Wei Jin
    Asuka Mochizuki
    Dayan B Goodenowe
    World Journal of Gastroenterology, 2015, (21) : 6604 - 6612
12345